Geoffrey Michael Glass - 01 Sep 2023 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Director
Signature
/s/ Jerad G. Seurer, as attorney-in-fact
Issuer symbol
AVDL
Transactions as of
01 Sep 2023
Net transactions value
$0
Form type
4
Filing time
01 Sep 2023, 21:30:13 UTC
Previous filing
11 Aug 2023
Next filing
01 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVDL Stock Option (Right to Buy) Gift $0 -33,000 -100% $0.000000* 0 01 Sep 2023 ADSs 33,000 $14.10 Direct F1, F2
holding AVDL Stock Option (Right to Buy) 33,000 01 Sep 2023 ADSs 33,000 $14.10 By Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options shall vest in full on the earlier to occur of (a) August 1, 2024 or (b) the date of the next annual general meeting of shareholders following the date of grant (August 1, 2023), subject to the Reporting Person's continued service on the Board of Directors at such time.
F2 The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
F3 On September 1, 2023, the Reporting Person transferred 33,000 options to the Geoffrey M. Glass Revocable Trust u/t/d August 26, 2020, of which the Reporting Person is trustee. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust.